menu toggle

White paper: Harnessing the power of adaptation

By Paula Pulsoni, Kim McLeod, MPH

Adaptive trials offer considerable flexibility benefits for pharmaceutical companies compared with alternatives. They are designed to enable more rapid recruitment of participants, utilizing fewer resources while also minimizing the safety risk to patients.

Discover how adaptive design can support the success of complex clinical trials in this white paper, put together with our partners at Xcenda, where we assess the benefits and risks associated with adaptive design and look at the learnings we can take from this approach. 


About The Authors

Paula Pulsoni
Vice President, Sales and Services
World Courier
View Bio
Kim McLeod, MPH
Senior Director, Prospective Clinical Research
Xcenda
View Bio